-
Merck, Hanwha to develop Enbrel biosimilar
WHITEHOUSE STATION, N.J. — Merck will collaborate with a Korean manufacturer to develop a biosimilar version of a drug used for autoimmune diseases.
Merck, which operates outside the United States and Canada as MSD to avoid confusion with Germany-based Merck KGaA, announced Monday a collaboration with Seoul, South Korea-based Hanwha Chemical to develop and commercialize HD203, a biosimilar version of Enbrel (etanercept), made by Amgen and Pfizer. The drug is used to treat such disorders as rheumatoid arthritis and psoriasis.
-
Men’s Health Network, Abbott underscore health issues through T-Talk Tune-Up campaign
NEW YORK — A new survey indicated that almost 70% of men have an easier time taking care of their cars than their own health.
The survey of 501 men ages 45 to 65 years, which was commissioned by the Men’s Health Network and drug maker Abbott, also found that more than 40% would be more likely to address car issues than health issues, while 28% don’t visit the doctor regularly, and 56% said they were more worried about their spouse’s health than their own.